Progranulin as marker for autoimmune disorders
Autoantibodies to progranulin in samples from subjects suffering from ANCA-associated and ANCA-negative primary systemic vasculitides as well as in other autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis have been identified. In addition, also progranulin with a specific posttranslational modification and aberrant forms of progranulin in these autoimmune patientshas been found.
A neutralizing effect of anti-progranulin autoantibodies on progranulin plasma levels, which is of particular interest in the light of progranulin’s function as a potent direct inhibitor of TNFR-1&2 has been demonstrated as well as the fact, that the presence of anti-progranulinautoantibodies is significantly associated with active disease.
Further Information: PDF
Universität des Saarlandes Wissens- und Technologietransfer GmbH PatentVerwertungsAgentur der saarländischen Hochschulen
Phone: +49 (0)681/302-71302
Contact
Dipl.-Kfm. Axel Koch (MBA), Dr. Conny Clausen, Dr. Nicole Comtesse, Dr. Frank Döbrich
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Sea slugs inspire highly stretchable biomedical sensor
USC Viterbi School of Engineering researcher Hangbo Zhao presents findings on highly stretchable and customizable microneedles for application in fields including neuroscience, tissue engineering, and wearable bioelectronics. The revolution in…
Twisting and binding matter waves with photons in a cavity
Precisely measuring the energy states of individual atoms has been a historical challenge for physicists due to atomic recoil. When an atom interacts with a photon, the atom “recoils” in…
Nanotubes, nanoparticles, and antibodies detect tiny amounts of fentanyl
New sensor is six orders of magnitude more sensitive than the next best thing. A research team at Pitt led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich…
